Rv0129c: fbpCRv0340Rv0341: iniBRv0342: iniARv0343: iniCRv1483: mabARv1484: inhARv1854c: ndhRv1592cRv1772Rv1908c: katG1909c: furARv2242: srm R homologRv2243: fabDRv2245: kasARv2247: accD6Rv2427A: oxyRRv2428: ahpCRv2846c: efpARv3139: fadE24Rv3566c: nhoARv3795: embB

Rv1908c

More about Rv1908c on    TBDB.org

More about Rv1908c on    TubercuList

Return to gene list

Display all mutations or select a bar from the histogram above to examine in greater detail

Display high confidence mutations only

Rv1908c: Codons 180 to 199: 8 mutations (high confidence mutations are highlighted in yellow)
Primary reference Polymorphism Nucleotide position Codon position Amino acid Time period Origin Molecular detection method Gene coverage Resistance pattern MIC Susceptibility testing method R/Total isolates R/S isolates with mutation Additional mutations High confidence support
Secondary Publication: Hazbon MH AAC 2006 ACG/AAG 539 180 Thr/Lys - - - - - - - - - - -
Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 ACG/??? See Note 180 Thr/Cys - - - - - - - - - - -
Chan RCY JAC 2007 GGC/GTC 557 186 Gly/Val 1994-2004 Hong Kong PCR-SSCP, Sequencing Whole gene N.S. - Absolute concentration method 250 241 1 -
Chan RCY JAC 2007 GGC/CAC 556-557 186 Gly/His 1994-2004 Hong Kong PCR-SSCP, Sequencing Whole gene N.S. - Absolute concentration method 250 241 1 -
Baker LV AAC 2005 TGG/CGG 571 191 Trp/Arg 1998 United Kingdom Directed Oligonucleotide array, Sequencing Whole gene H,HS,HE,HSE,MDR ratio>=4 Resistance ratio method 202/378 1/0 - -
Chan RCY JAC 2007 del G 572 191 Frameshift 1994-2004 Hong Kong PCR-SSCP, Sequencing Whole gene N.S. - Absolute concentration method 250 241 1 -
Morlock GP AAC 2003 G/A 583 195 Glu/Lys 2003 USA Sequencing Whole gene Eth 1 Microplate alamar blue assay 17/41 0/1 nt 280 T/G inh ORF -
Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 TGG/TGA 594 198 Trp/STOP - - - - - - - - - - -

Disclaimer: These are all putative mutations found in drug resistant clinical TB isolates. No a priori decisions have been made as to whether these mutations are causally related to resistance or possible secondary mutations.


© 2010 Andreas Sandgren  |  Supported by the Swedish Research Council  |  Contact Database Curator